Lesch-Nyhan syndrome (LNS) is a chronic, progressive neurodevelopmental disorder causing motor and behavioral dysfunction due to decreased synthesis of the enzyme hypoxantine-guanine phosphoribosyltransferase (HPRT). Affected boys have mental retardation, delayed development, extrapyramidal motor disturbances and self-injuring behavior. As hematopoietic stem cell transplantation (HSCT) has been shown to be effective in several neurodevelopmental inborn errors, we hypothesized that it could be favorable in LNS as well. Following a myeloablative conditioning regimen (busulphan 3.2 mg/kg/day for 4 days, cyclophosphamide 60 mg/kg/day for 2 days with ATG Thymoglobin 2.5 mg/kg/day for 4 days) an unrelated umbilical cord blood unit was transfused at the age of 2 years. The graft was a 6/6 HLA-matched at HLA-A, B loci by antigen level, and at DRB1 by allelic level typing. Infused total nucleated cell dose was 3.6 × 10e7 per kilogram body weight. Serum HPRT levels reached normal values by the end of the sixth month post transplant. Slow neurodevelopmental improvement seen during the three-year follow-up and the missing self-injuring behavior can be considered as a proof for the presence of enzyme-competent cells behind the blood–brain barrier.
This is a preview of subscription content, log in to check access.
HPRT and APRT activity was measured in the Molecular Genetics and Metabolism Laboratory, München, Germany by Prof. Dr. med. habil. Y. S. Shin.
Conflict of interest
The authors declare no conflict of interest.
The authors received no support for the work and declare no conflict of interest
This investigational procedure was approved by the Ethics Committee of the Hungarian Medical Research Council
Hematopoietic stem cell transplantation can be considered as an ameliorating procedure in Lesch-Nyhan syndrome
Dressel D, Ritter CA, Sperker B et al (2003) Busulfan induces activin A expression in vitro and in vivo: a possible link to venous occlusive disease. Clin Pharmacol Ther 74(3):264–274PubMedCrossRefGoogle Scholar
Enders W, Helmig M, Shin YS et al (1991) Bone marrow transplantation in Lesch-Nyhan disease. J Inherit Metab Dis 14:270–271CrossRefGoogle Scholar
Hladnik U, Nyhan WL, Bertelli M (2008) Variable expression of HPRT deficiency in 5 members of a family with the same mutation. Arch Neurol 65:1240–1243PubMedCrossRefGoogle Scholar
Jinnah HA, De Gregorio L, Harris JC et al (2000) The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res 463(3):309–326PubMedCrossRefGoogle Scholar
Jinnah HA, Ceballos-Picot I, Torres RJ et al (2010) Attenuated variants of Lesch-Nyhan disease. Brain 133(Pt 3):671PubMedCrossRefGoogle Scholar
Krivit W, Sung JH, Shapiro EG, Lockman LA (1995) Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 4(4):385PubMedCrossRefGoogle Scholar
Mahmood A, Dubey P, Moser HW, Moser A (2005) X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatr Transplant 9(Suppl 7):55PubMedCrossRefGoogle Scholar
Mak BS, Chi CS, Tsai CR, Lee WJ, Lin HY (2000) New mutations of the HPRT gene in Lesch-Nyhan syndrome. Pediatr Neurol 23(4):332PubMedCrossRefGoogle Scholar
Nyhan WL, Parkman R, Page T et al (1985) Bone marrow transplantation in Lesch-Nyhan disease. Adv Exp Med Biol 195A:167–170CrossRefGoogle Scholar
Palella TD, Hidaka Y, Silverman LJ et al (1989) Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector. Gene 80(1):137–144PubMedCrossRefGoogle Scholar
Puig JG, Torres RJ, Mateos FA et al (2001) The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 80(2):102CrossRefGoogle Scholar
Sarafoglou K, Grosse-Redlinger K, Boys CJ et al (2010) Lesch-Nyhan variant syndrome: variable presentation in 3 affected family members. Arch Neurol 67:761–764PubMedCrossRefGoogle Scholar
Southgate TD, Bain D, Fairbanks LD et al (1999) Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium. Metab Brain Dis 14(4):205–221PubMedCrossRefGoogle Scholar
Sun TQ, Livanos E, Vos JM (1996) Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes. Gene Ther 3(12):1081–1088PubMedGoogle Scholar
Vassord C, Lapouméroulie C, Koumaravelou K, Srivastava A, Krishnamoorthy R (2008) Endothelial cells do not express GSTA1: potential relevance to busulfan-mediated endothelialdamage during haematopoietic stem cell transplantation. Eur J Haematol 80(4):299–302PubMedCrossRefGoogle Scholar
Wade-Martins R, White RE, Kimura H, Cook PR, James MR (2000) Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat Biotechnol 18(12):1311–1314PubMedCrossRefGoogle Scholar
Wojcik BE, Jinnah HA, Muller-Sieburg CE, Friedmann T (1999) Bone marrow transplantation does not ameliorate the neurolgic symptoms in mice deficient in hypoxanthine-guanine phosphoribosyl transferase (HPRT). Metab Brain Dis 14(1):57–65PubMedCrossRefGoogle Scholar